Latest Production News

Actinogen Medical reports steady progress in its Alzheimer’s and depression drug trials, backed by strong funding and strategic commercial planning. Key interim data from the pivotal XanaMIA trial is expected early next year.

Embelton Limited reports a notable decline in revenue and profit for FY2025 amid a challenging construction market, yet maintains its dividend payout, signaling cautious optimism.

Dome Gold Mines has updated the schedule for its Share Purchase Plan, setting new dates for offer opening, closing, and share issuance through September 2025. This move aligns with ongoing development efforts at its Fiji-based mining projects.

Asset Vision Co Limited reported a 22.9% increase in revenue to $5.03 million for FY2025, alongside a widening net loss of $385,797. The company’s Annual Recurring Revenue surged 28%, supported by new contracts and product innovation.

Polynovo Limited reported a robust 23.3% increase in total revenue for FY25, driven by strong commercial sales growth across the US and international markets. The company is advancing its FDA PMA submission and expanding its global footprint amid strategic product development.

PolyNovo Limited reported a robust 28.9% increase in group sales to A$118.6 million for FY25, alongside a 151% surge in net profit after tax to A$13.2 million, driven by strong U.S. growth and key regulatory approvals.

Ark Mines has landed a $4.5 million investment from Queensland’s Critical Minerals and Battery Technology Fund, accelerating development at its Sandy Mitchell rare earths project with production targeted for late 2027.

Ambertech Limited reported a 6% increase in revenue to $101.2 million for FY25, yet net profit after tax fell sharply by 38% to $0.84 million amid inflationary pressures and increased costs. The company declared a fully franked final dividend and remains optimistic about FY26.

Kogan.com Ltd reported robust FY25 growth driven by its core platform, despite setbacks from Mighty Ape's platform migration. The company declared a solid dividend and outlined a cautious but optimistic FY26 outlook.

Kogan.com Ltd reported robust FY25 results with strong sales growth, margin improvement, and a rapidly expanding customer base, while navigating challenges at Mighty Ape. The company outlined ambitious plans to boost profitability through platform-based sales and product margin optimisation.

Vital Metals Limited has had its trading suspension lifted following announcements addressing an ASX Price and Volume Query and a new capital raise, signaling renewed market activity.

Kogan.com Ltd reported robust FY25 growth with a 35% increase in active customers and a 20.5% rise in platform sales revenue, offset by a significant goodwill impairment at subsidiary Mighty Ape. The group declared a 7.0 cent final dividend and announced key board changes.